Not Signed In -
Bupropion SR |
Budeprion SR; Wellbutrin SR |
Clinical Trial: Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
This study has been completed.
Purpose
The purpose of this study is to evaluate dopamine reuptake inhibitors for cocaine abuse.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Cocaine-Related Disorders | Drug: Bupropion | Phase I |
MedlinePlus related topics: Cocaine Abuse
Study Type: Interventional
Study Design: Treatment, Uncontrolled
Official Title: Dopamine Reuptake Inhibitors of Cocaine Abuse
Eligibility
Ages Eligible for Study: 18 Years - 45 Years, Genders Eligible for Study: Both
Criteria
Please contact site for information.
Location Information
Connecticut
VA Connecticut Healthcare System, New Haven, Connecticut, 06519, United States
Study chairs or principal investigators
Thomas R Kosten, M.D., Principal Investigator, VA Connecticut Healthcare System
More Information
Study ID Numbers: NIDA-09250-1; P50-09250-1
Record last reviewed: December 2002
Last Updated: November 18, 2004
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000276
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: December 2002
Last Updated: November 18, 2004
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000276
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
